Skip to main content

Gastric Cancer OnlineFirst articles

Open Access 18.04.2024 | Original Article

International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape

Bertinoro Workshop, November 2022

Gastric cancer is still one of the leading causes of cancer-related deaths worldwide, with over one million of new cases in 2020 and an estimated 769,000 deaths, ranking fifth for incidence and fourth for mortality globally [ 1 ].

verfasst von:
Paolo Morgagni, Maria Bencivenga, Fatima Carneiro, Stefano Cascinu, Sarah Derks, Maria Di Bartolomeo, Claire Donohoe, Clarisse Eveno, Suzanne Gisbertz, Peter Grimminger, Ines Gockel, Heike Grabsh, Paulo Kassab, Rupert Langer, Sara Lonardi, Marco Maltoni, Sheraz Markar, Markus Moehler, Daniele Marrelli, Maria Antonietta Mazzei, Davide Melisi, Carlo Milandri, Paul Stefan Moenig, Bianca Mostert, Gianni Mura, Wojciech Polkowski, John Reynolds, Luca Saragoni, Mark I. Van Berge Henegouwen, Richard Van Hillegersberg, Michael Vieth, Giuseppe Verlato, Lorena Torroni, Bas Wijnhoven, Guido Alberto Massimo Tiberio, Han-Kwang Yang, Franco Roviello, Giovanni de Manzoni

Open Access 17.04.2024 | Original Article

Adding salt to food at table as an indicator of gastric cancer risk among adults: a prospective study

Gastric cancer is the fifth most commonly diagnosed cancer globally [ 1 ], with the highest prevalence in Asia, followed by Eastern Europe and Latin Americas [ 1 – 3 ]. Gastric cancer risk increases with age and is more prevalent in males, while …

verfasst von:
Selma Kronsteiner-Gicevic, Alysha S. Thompson, Martina Gaggl, William Bell, Aedín Cassidy, Tilman Kühn

11.04.2024 | Letter to the Editor

Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer

verfasst von:
Hyung-Don Kim, Min-Hee Ryu, Ji Sung Lee, Yoon-Koo Kang

07.04.2024 | Original Article

Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancer

Gastric cancer (GC) is the fifth most diagnosed malignancy worldwide, with over 1 million estimated new cases annually [ 1 ], and it is the third leading cause of global cancer mortality [ 2 ], with an average 5-year survival rate of only …

verfasst von:
Yingli Fu, Jing Jiang, Yanhua Wu, Donghui Cao, Zhifang Jia, Yangyu Zhang, Dongming Li, Yingnan Cui, Yuzheng Zhang, Xueyuan Cao

04.04.2024 | Original Article

Precise highlighting of the pancreas by semantic segmentation during robot-assisted gastrectomy: visual assistance with artificial intelligence for surgeons

The infrapyloric and suprapancreatic lymph nodes, categorized as stations 6, 8a, 11p, and 11d by the Japanese gastric cancer association [ 1 ], should be dissected during radical gastrectomy for gastric cancer [ 2 ]. During lymphadenectomy around …

verfasst von:
Tatsuro Nakamura, Nao Kobayashi, Yuta Kumazu, Kyohei Fukata, Motoki Murakami, Shugo Kohno, Yudai Hojo, Eiichiro Nakao, Yasunori Kurahashi, Yoshinori Ishida, Hisashi Shinohara

Open Access 03.04.2024 | Original Article

Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019

Gastric cancer is a prevalent cancer worldwide, accounting for 5.6% of all new cancer cases (ranking fifth in incidence) and 7.7% of all cancer deaths (ranking fourth in mortality) in 2020 [ 1 ]. Gastric cancer is more often diagnosed in …

verfasst von:
Yunhao Li, Anne I. Hahn, Monika Laszkowska, Fang Jiang, Ann G. Zauber, Wai K. Leung

01.04.2024 | Original Article

Risk prediction model for gastric cancer within 5 years in healthy Korean adults

Gastric cancer is the sixth most common cancer in 2020, with 1.09 million cases worldwide [ 1 ]. East Asian countries, including South Korea, have recorded high incidence rates of gastric cancer [ 2 , 3 ]. Although the recent incidence of gastric …

verfasst von:
Hyungseok Oh, Sunwoo Cho, Jung Ah Lee, Seungho Ryu, Yoosoo Chang

31.03.2024 | Original Article

Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer

Globally, gastric cancer (GC) is the fourth leading cause of cancer related mortality and the fifth most commonly diagnosed cancer, responsible for over one million new cases in 2020 [ 1 ]. Although curative surgery is performed at localized stage …

verfasst von:
Chung Ryul Oh, Eo Jin Kim, Heejung Chae, Young Soo Park, Min-Hee Ryu, Hyung-Don Kim, Yoon-Koo Kang

Open Access 03.11.2019 | Correction

Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer

ping real-world comparators for …

verfasst von:
Ian Chau, Dung T. Le, Patrick A. Ott, Beata Korytowsky, Hannah Le, T. Kim Le, Ying Zhang, Teresa Sanchez, Gregory A. Maglinte, Melissa Laurie, Pranav Abraham, Dhiren Patel, Tong Shangguan